基线体重指数与乳腺癌复发动力学的关系
该研究纳入一项III期随机临床试验中734例淋巴结阳性乳腺癌患者,中位随访15.4年,按基线BMI分析远处复发动力学。结果显示,BMI与复发时间模式相关:ER阴性患者晚期复发风险主要见于超重和肥胖者;ER阳性绝经前肥胖患者呈现早期高峰及5年后第二峰;ER阳性绝经后超重患者复发率显著升高,肥胖者亦有晚期第二峰。
要点
- 基线BMI与乳腺癌复发的时间动力学相关,而非仅影响总复发风险。
- ER阴性乳腺癌的晚期复发风险主要归因于超重和肥胖患者。
- ER阳性绝经前肥胖患者呈现早期高峰及5年后第二峰。
核心结论
- 诊断时BMI与乳腺癌复发动力学相关,患者肥胖应作为晚期辅助治疗模式探索的核心因素。
研究设计与样本
- 从一项比较不同化疗方案的III期随机临床试验中获取734/777例淋巴结阳性乳腺癌患者的BMI,中位随访15.4年。
- 采用累积发生率估计和分段指数模型评估远处复发动力学,并按ER状态及绝经状态分层分析。
主要发现
- ER阴性乳腺癌中,晚期复发风险主要归因于超重和肥胖患者。
- ER阳性绝经前亚组中,肥胖与早期高窄峰相关,随访5年后出现另一主峰,超重患者风险介于肥胖与正常体重之间。
- ER阳性绝经后亚组中,超重患者远处复发率显著高于其他BMI类别,肥胖患者亦观察到晚期第二复发峰。
临床怎么用
- 对淋巴结阳性乳腺癌患者,应关注诊断时BMI以评估复发时间模式。
- 超重和肥胖患者可能需要针对晚期复发的个体化随访或辅助治疗策略。
局限性
- BMI数据仅来自734/777例患者,存在部分缺失。
- 研究为回顾性分析BMI与复发动力学关联,未报告具体效应量及置信区间。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In cancer follow-up, in addition to the evaluation of survival probabilities, there is a fundamental need of assessing recurrence dynamics for optimal disease management. Although the time-dependent effect of the oestrogen receptor (ER) status of the tumour has already been described, so far no factor has proven to disentangle the multi-peak behaviour observed for breast cancer recurrences. Here, we aimed at investigating whether adiposity at diagnosis, reflected by increased patient's body mass index (BMI), could be associated with breast cancer recurrence patterns over time after primary cancer therapy. METHODS: We retrieved BMI from 734 of 777 patients with node-positive breast cancer from a phase III randomised clinical trial, which compared different chemotherapy regimens and had a median follow-up of 15.4 years. Cumulative incidence estimation as well as piecewise exponential models were carried out to estimate the distant recurrence dynamics, in all patients, as well as in subgroups based on the ER status, with the ER-positive group being further split according to the menopausal status. RESULTS: In patients with ER-negative breast cancer, time-dependent analyses revealed that the hazard of late relapses could mainly be attributed to the overweight and obese patients. Within the subgroup of premenopausal patients with ER-positive tumours, obesity was associated with an early high narrow peak of distant recurrences followed by another main peak after 5 years of follow-up. The risk for overweight patients was intermediate between obese and normal-weight patients. In the postmenopausal subgroup of patients with ER-positive tumours, the distant recurrence rate was significantly more elevated in the overweight patients compared to the other BMI categories, and a second late peak of recurrences was also observed for the obese patients. CONCLUSION: These results demonstrate that the patient's BMI at diagnosis is associated with cancer recurrence dynamics. Patient adiposity should therefore be central to the exploration of late adjuvant treatment modalities.
引用
- Biganzoli E, Desmedt C, Fornili M, et al. Recurrence dynamics of breast cancer according to baseline body mass index. Eur J Cancer. 2017. PMID: 29096156. doi:10.1016/j.ejca.2017.10.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。